Tumor Lysis Syndrome Induced by Radiotherapy in Non-Small Cell Lung Cancer.

Author: Dong Hyo NOH ¹ ; Ki Eun HWANG ; Jeong Hyun SHIN ; Dong KIM ; Kyung Hwa CHO ; Keum Ha CHOI ; Seong Hoon PARK ; Eun Taik JEONG ; Hak Ryul KIM
Author Information

1. Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea. kshryj@wonkwang.ac.kr
Publication Type:Case Report
Keywords: Tumor lysis syndrome; Radiotherapy; Non-small cell lung carcinoma
MeSH: Carcinoma, Non-Small-Cell Lung; Creatinine; Emergencies; Hematologic Neoplasms; Humans; Hyperkalemia; Hyperphosphatemia; Hypocalcemia; Tumor Lysis Syndrome
From:Journal of Lung Cancer 2010;9(2):106-109
CountryRepublic of Korea
Language:English
Abstract: Tumor lysis syndrome (TLS) is an oncologic emergency that is characterized by numerous metabolic abnormalities, including hyperuricemic nephropathy, hyperphosphatemia, hypocalcemia, hyperkalemia and increased serum creatinine. This syndrome is common for tumors with rapid cell turnover and growth rates, and for bulky tumors with high sensitivity to anti-neoplastic treatments. Hence, TLS is a well-recognized clinical problem in hematologic malignancies. TLS is rarely observed to be induced in solid tumors by chemotherapy. Herein we present the second case of TLS that developed during radiotherapy in a patient with non-small cell lung cancer.